New study shows how AI can improve recovery in stroke patients - TechRepublic

The American Heart Association published the results of a trial that shows stroke survivors are twice as likely to take anti-blood clot treatments when they are using an artificial intelligence (AI) platform, compared to those receiving more traditional treatment. The AI platform, AiCure, uses software algorithms on smartphones to confirm patient identify, the medication, and if the medication was taken. Patients receive automated reminders and dosing instructions as well. Healthcare workers receive real-time data which allows for early detection of patients who are not taking their meds as scheduled. SEE: Google's DeepMind and the NHS: A glimpse of what AI means for the future of healthcare (ZDNet) This latest trial, which lasted 12 weeks and was published in the American Heart Association's journal Stroke, shows more of AI's potential.